Abstract:Purpose: The main aim of the present work was to prepare matrix sustained release pellets of poorly soluble drugs with satisfactory dissolution profiles. Methods: Nimodipine (NMD) was selected as a model drug. In order to improve the dissolution of NMD, coground mixtures were obtained by cogrinding NMD and other excipients (chitosan, MCC and mannitol) with sodium dodecyl sulphate (SDS), crospovidone (Polyplasdone XL-10) and croscarmellose sodium (Ac-Di-Sol). The coground mixtures were made into pellets directly by extrusion-spheronisation. The drug state in the carriers was evaluated by differential scannning calorimetry (DSC), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). Results: The endothermic peak intensity of NMD crystals exhibited a reduction and a new peak was observed at 149°C on DSC thermograms of a coground mixture containing 20% SDS (CGM1). The endotherimic peak of NMD at 125.07°C disappeared in the curve of the coground mixture containing polyplasdone XL-10 (CGM2) and that containing Ac-Di-Sol (CGM3).The DSC, PXRD and SEM results confirmed the microcrystalline state of NMD in CGMs. The drug release from the coground mixtures increased on increasing the cogrinding time up to 240 min. All of the pellet formulations exhibited sustained release profiles. The dissolution of coground mixtures was significantly increased when compared with that of physical mixtures. Ac-Di-Sol was found to be the most effective in improving the release of NMD both from the coground mixture and the pellets made from it. However, drug release from pellets containing polyplasdone XL-10 was the lowest. Both chitosan and MCC acted as matrix materials which produced sustained release profiles. Conclusion: The preparation of a coground mixture containing Ac-Di-Sol significantly increased the dissolution rate of NMD. In addition, matrix sustained release pellets could be obtained using the coground mixtures.

Preparation and Evaluation of 1-Deoxynojirimycin Sustained-Release Pellets Vs Conventional Immediate-Release Tablets

Preparation of 1-Deoxynojirimycin Controlled Release Matrix Pellets of Capsules and Evaluation in Vitro-in Vivo to Enhance Bioavailability

Development and Evaluation of 1-Deoxynojirimycin Sustained-Release Delivery System: in Vitro and in Vivo Characterization Studies

Study on pramipexole dihydrochloride sustained-release tablets

In vitro and in vivo évaluation of naringin sustained-release pellets compared with immediate-release tablets

Preparation of sustained release pellets of poorly soluble drugs by cogrinding and extrusion-spheronisation

Optimization and Characterization of Novel Sustained Release Supermicro-Pellet Based Dry Suspensions That Load Dexibuprofen

Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin

Preparation of Nitrendipine Sustained-Release Pellet Using Extrusion-Spheronization Technology and Investigations of Its Formulation

Development of Sinomenine Hydrochloride Sustained-release Pellet With Multiple Release Characteristics

Design, in vitro release characterization and pharmacokinetics of novel controlled release pellets containing levodropropizine.

Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride

Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability

Preparation and in Vitro Release Study of Sustained-release Coated Pellets Containing Clarithromycin

Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.

Preparation and evaluation of sustained-release diltiazem hydrochloride pellets

Preparation and In-Vitro Release of Metformin Hydrochloride Sustained-Release Pellets

Preparation and Release Test of Nicotinic Acid Sustained-Release Pellets

Preparation of Sinomenine Hydrochloride Enteric-coated and Sustained-release Pellets

STUDY ON THE PREPARATION OF SUSTAINED-RELEASE AND PULSATILE PELLETS OF DILTIAZEM HYDROCHLORIDE

Preparation and in vitro Dissolution of Gliclazide Sustained-release Tablets